(4S)-4-Benzyl-N-{[(4S)-4-benzyl-2-oxo-1,3-oxazolidin-3yl]sulfonyl}-2-oxo-1,3-oxazolidine-3-carboxamide

dc.contributor.authorMalika Berredjem
dc.date.accessioned2024-02-15T08:04:38Z
dc.date.available2024-02-15T08:04:38Z
dc.date.issued2010-06-01
dc.description.abstractThe title compound, C 21 H 21 N 3 O S, contains an oxazolidinone ring and a sulfonamide group, both characteristic for biologically and pharrmaceutically active compounds. Both stereogenic centres reveal an S absolute configuration. The two oxazolidinone rings are in an envelope conformation with the methylene carbon flap atoms deviating by 0.428 (1) and 0.364 (2) A 7 ˚ from the best least-square planes formed by the four other ring atoms. An intramolecular N—H O hydrogen bond contributes to the folded conformation of the molecule. In the crystal, weak intermolecular C—H O interactions connect the molecules into helices along the the twofold screw axes.
dc.identifier.issn1600-5368
dc.identifier.urihttp://dspace.univ-khenchela.dz:4000/handle/123456789/1088
dc.language.isoen
dc.title(4S)-4-Benzyl-N-{[(4S)-4-benzyl-2-oxo-1,3-oxazolidin-3yl]sulfonyl}-2-oxo-1,3-oxazolidine-3-carboxamide
dc.title.alternative(4S)-4-Benzyl-N-{[(4S)-4-benzyl-2-oxo-1,3-oxazolidin-3yl]sulfonyl}-2-oxo-1,3-oxazolidine-3-carboxamide
dc.typeArticle
Files
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed to upon submission
Description: